FDA Inspection 731926 — Aquestive Therapeutics

Aquestive Therapeutics — FEI 3004395604

The FDA completed an inspection of Aquestive Therapeutics on Jun 28, 2011 in Portage, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 28, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Portage, IN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
241921 CFR 211.198(a)Complaint Handling Procedure